Literature DB >> 10704728

Enkephalin-degrading enzymes and their inhibitors in human saliva.

M Marini1, L G Roda.   

Abstract

The possible presence of enzymes able to hydrolyze leucine enkephalin has been investigated in human saliva. The data obtained indicate that, in the presence of saliva, Leu-enkephalin is partially hydrolyzed. The disappearance of the substrate is paired with the formation of hydrolysis byproducts whose composition indicates the presence of all three classes of enzymes known to hydrolyze enkephalins: aminopeptidases, dipeptidylaminopeptidases, and dipeptidylcarboxypeptidases. The presence of low molecular weight substances with inhibitory activity on proteolytic enzymes has also been detected. These substances are active on all three classes of enkephalin-degrading enzymes, although the inhibition is more evident on dipeptidylpeptidases than on aminopeptidases. Substrate degradation was found to be higher in male than in female saliva: this seems to be caused by the activities both of enzymes and low molecular weight inhibitors that are different in the two sexes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704728     DOI: 10.1016/s0196-9781(99)00182-5

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  2 in total

1.  Different effects of steroidal therapy on neuropeptide-active enzymes in male and female human saliva.

Authors:  Federica Albo; Riccardo Antonangeli; Antonella Cavazza; Mario Marini; L Giorgio Roda; Paolo Rossi
Journal:  Neurochem Res       Date:  2002-09       Impact factor: 3.996

2.  Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study.

Authors:  Yves Boucher; Adeline Braud; Evelyne Dufour; Scarlette Agbo-Godeau; Vanessa Baaroun; Vianney Descroix; Marie-Thérèse Guinnepain; Marie-Noëlle Ungeheuer; Catherine Ottone; Catherine Rougeot
Journal:  Clin Oral Investig       Date:  2016-11-10       Impact factor: 3.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.